Table 1.

Clinical and pathologic data of pancreatic adenocarcinoma shown by Sp1 immunohistochemical staining results

SP1-positive tumors (n = 17)SP1-negative tumors (n = 25)P
Sex, n (%)
    Female4 (22)14 (78)0.057
    Male13 (54)11 (46)
Age, y
    Mean (SD)66.1 (11.9)65.7 (10.4)0.853
Tumor differentiation, n (%)
    Well2 (22)7 (78)0.036
    Moderate6 (30)14 (70)
    Poor9 (69)4 (31)
Tumor stage, n (%)
    IA02 (100)<0.001
    IB04 (100)
    IIA011 (100)
    IIB14 (74)5 (26)
    III2 (67)1 (33)
    IV1 (50)1 (50)
Tumor size, cm
    Mean (SD)4.2 (3.0)3.0 (1.6)0.071
Tumor metastasis, n (%)
    No020 (100)<0.001
    Yes17 (77)5 (23)
No. lymph nodes
    Median15160.879
    Mean (SD)15.78 (10.22)16.60 (11.32)